A Risk Sciences International news item posted on June 29, 2016 and last updated on August 18, 2019
This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

To read this article, please click here.

More RSI News

Dr. Donald R. Mattison co-authors: Adult Utilization of Psychiatric Drugs

December 12, 2016

Because there is limited information available concerning the use of psychiatric drugs among the US adult population, Drs Moore and Mattison sought to characterize adult…

RSI launches game-changing climate app

June 30, 2016

RSI launched the Climate Change Hazards Information Portal (CCHIP).

Climate change modelling for the Bow River watershed

June 29, 2016

Following up on the recommendations put forth by the Expert Management Panel on River Flood Mitigation, the Environmental and Safety Management (ESM) and Water Resources (WS)…

QuarterWatch analyzes MedWatch Reports

June 29, 2016

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs…